MetaBiom
Microbiome & Chronic Diseases

Evidence Based Medicine
Sign in

Bifidobacteria {10000259}

Record Keys


Organism:
Bifidobacteria
Class:[  ]

Details


Initialisation date:
2020-10-01

Meta Information


Taxonomy:[  ]
Domain:
Bacteria
Zone:
Gut Lumen
Enzyme:[  ]
Function:[  ]

Notes


[  ]

Shared Notes


  • [1.7
    - The reduction of Bifidobacteria, the main producers of lactic acid capable of suppressing the growth of pathogenic bacteria, leads to an alteration of the immunitary system.
  • [1.8
    - Dietary fiber > competitive advantage to Bifidobacteria
  • [1.9
    - Loss of Bifidobacterium early in life has been associated with increased risk of developing autoimmunity, as seen in a birth cohort in Finland and atopic wheeze in another cohort in rural Ecuador.
  • [1.10
    - At the phylum level, Firmicutes were the dominant phylum in 95% of all meconium samples (highest abundance observed in the VPT neonates as compared to PT and FT neonates); the second most dominant phylum was Bacteroidetes in 50% of all meconium samples.
  • [1.11
    - Macrolide exposure was associated with reduced richness for twice as long as penicillin.
    - Antbiotic at childhud > reduced Bifidobacteria (5 studies) and Lactobacillus (2 studies), and significant increases in Proteobacteria such as E. coli (4 studies).


[Overlap other Organisms per Disease]

OrganismOverlapCommon increased in DiseaseCommon decreased in Disease
Bifidobacteria 1.0000 1 (1.00) : Autoimmune Thyroid Disorders 2 (1.00) : Chronic fatigue syndrome | Covid-19
Syntrophococcus 0.1250 0 (0.00) 1 (0.25) : Chronic fatigue syndrome
Asaccharobacter 0.0833 0 (0.00) 1 (0.17) : Chronic fatigue syndrome
Ruminococcus obeum 0.0625 0 (0.00) 1 (0.12) : Covid-19
Holdemania 0.0500 0 (0.00) 1 (0.10) : Chronic fatigue syndrome
Agathobacter 0.0500 0 (0.00) 1 (0.10) : Covid-19
Eubacterium ventriosum 0.0417 0 (0.00) 1 (0.08) : Covid-19
Bifidobacteriaceae 0.0417 0 (0.00) 1 (0.08) : Chronic fatigue syndrome
Dorea formicigenerans 0.0417 0 (0.00) 1 (0.08) : Covid-19
Romboutsia 0.0417 0 (0.00) 1 (0.08) : Covid-19
Turicibacter 0.0250 0 (0.00) 1 (0.05) : Chronic fatigue syndrome
Ruminococcaceae 0.0238 0 (0.00) 2 (0.05) : Chronic fatigue syndrome | Covid-19
Eubacterium hallii 0.0227 0 (0.00) 1 (0.05) : Covid-19
Fusicatenibacter 0.0167 0 (0.00) 1 (0.03) : Covid-19
Firmicutes 0.0156 0 (0.00) 1 (0.03) : Chronic fatigue syndrome
Faecalibacterium 0.0143 0 (0.00) 2 (0.03) : Chronic fatigue syndrome | Covid-19
Eubacterium 0.0125 0 (0.00) 1 (0.02) : Chronic fatigue syndrome
Eubacterium rectale 0.0114 0 (0.00) 1 (0.02) : Covid-19
Bacteroidetes 0.0096 0 (0.00) 1 (0.02) : Chronic fatigue syndrome
Anaerostipes 0.0086 0 (0.00) 1 (0.02) : Covid-19
Coprococcus 0.0056 0 (0.00) 1 (0.01) : Covid-19
Ruminococcus 0.0054 0 (0.00) 1 (0.01) : Chronic fatigue syndrome
Faecalibacterium prausnitzii 0.0053 0 (0.00) 1 (0.01) : Covid-19
Lachnospiraceae 0.0052 0 (0.00) 1 (0.01) : Covid-19
Blautia 0.0048 0 (0.00) 1 (0.01) : Covid-19
Roseburia 0.0045 0 (0.00) 1 (0.01) : Covid-19
Bifidobacterium 0.0042 0 (0.00) 1 (0.01) : Chronic fatigue syndrome
Bacteroides 0.0038 0 (0.00) 1 (0.01) : Chronic fatigue syndrome

[Overlap Other Organisms per Factor]

OrganismOverlapCommon increased in FactorCommon decreased in Factor
Bifidobacteria 0.7222 2 (0.44) : Consumption of Lactulose | Intake of heat-treated lactobacilli 3 (1.00) : Antibiotic Therapy | High-fat diet | Milk Formula-feeding
Clostridiales 0.3333 0 (0.00) 2 (0.67) : Antibiotic Therapy | High-fat diet
Coriobacteriales 0.1667 0 (0.00) 1 (0.33) : Antibiotic Therapy
Bacteroidaceae 0.1667 0 (0.00) 1 (0.33) : High-fat diet
Bifidobacteriaceae 0.1667 0 (0.00) 1 (0.33) : High-fat diet
Verrucomicrobia 0.1667 0 (0.00) 1 (0.33) : High-fat diet
Bacteroidetes 0.0833 0 (0.00) 1 (0.17) : High-fat diet
Lactobacilli 0.0833 0 (0.00) 1 (0.17) : Milk Formula-feeding
Lactobacillales 0.0833 0 (0.00) 1 (0.17) : Antibiotic Therapy
Akkermansia 0.0556 0 (0.00) 1 (0.11) : High-fat diet
Ruminococcaceae 0.0556 0 (0.00) 1 (0.11) : High-fat diet

Common References